IPG Photonics (IPGP) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue declined 24% year-over-year to $257.6–$258 million, driven by weak industrial and e-mobility demand, with OEM inventory management and increased competition in China.
Gross margin fell to 37.3% from 43.4% a year ago, mainly due to lower manufacturing absorption and higher inventory reserves.
Net income dropped to $20.2 million, or $0.45 per diluted share, down 66%–68% year-over-year.
Strong cash flow from operations ($53 million in Q2) enabled $122 million in share repurchases and significant inventory reduction.
CEO transition to Dr. Mark Gitin in June 2024, with a focus on innovation, operational efficiency, and expanding technological leadership.
Financial highlights
Q2 2024 revenue: $257.6–$258 million, down 24% year-over-year; gross margin: 37.3%, down from 43.4%.
Net income: $20.2 million; diluted EPS: $0.45; operating income: $12 million (4.7% margin), all down sharply year-over-year.
Cash provided by operations: $53 million; capital expenditures: $24 million.
Cash and cash equivalents at June 30, 2024: $720.5 million; short-term investments: $343.4 million; no debt.
Book-to-bill ratio below 1 for the quarter, with Europe weakest, North America stable, and Asia showing relative strength.
Outlook and guidance
Q3 2024 revenue expected between $210 million and $240 million; gross margin guidance is 34%–37%.
Q3 EPS guidance: $0.00–$0.30 per diluted share; operating expenses projected at $82–$84 million.
No meaningful recovery in laser sales expected until sometime in 2025 due to continued macroeconomic uncertainty and delayed EV investments.
Management expects continued margin pressure from higher operating costs and supply chain adjustments due to sanctions.
Capital expenditures for 2024 projected at $120–$130 million, focused on expanding capacity outside Russia.
Latest events from IPG Photonics
- Growth driven by innovation, new markets, and strong financials positions the business for expansion.IPGP
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Q4 revenue up 17% year-over-year, with strong gains in medical and advanced applications.IPGP
Q4 202512 Feb 2026 - Transitioning from legacy cutting to high-growth welding, EV, and medical markets, with robust innovation.IPGP
The Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Q3 revenue dropped 23% and net loss hit $233.6M, but adjusted EPS was $0.29.IPGP
Q3 202418 Jan 2026 - Industrial laser innovation, market diversification, and stable financials drive future growth.IPGP
Bank of America Global Industrials Conference 202526 Dec 2025 - Poised for growth with strong cash flow, margin recovery, and expanding opportunities in new markets.IPGP
Raymond James 46th Annual Institutional Investors Conference23 Dec 2025 - Q4 revenue dropped 22% YoY, but gross margin and cash flow improved amid weak demand.IPGP
Q4 202417 Dec 2025 - Shareholders to vote on directors, pay, new incentive plan, and auditor amid strategic shifts.IPGP
Proxy Filing1 Dec 2025 - Director elections, executive pay, incentive plan, and auditor ratification up for vote May 20, 2025.IPGP
Proxy Filing1 Dec 2025